Jilin Aodong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 115% in First Half of 2023

Jilin Aodong Pharmaceutical Group Co.,Ltd. (吉林敖东药业集团股份有限公司) (000623.SZ) reported a net profit of 1.1 billion yuan in the first half of 2023, up 115% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 26.6% year-on-year.

At the end of the reporting period, it had 32.3 billion yuan in total assets and 5.1 billion yuan in total liabilities, with a liability-to-asset ratio of 15.9%.